Dublin-based CRO Icon had adopted a new digital platform developed with Dimension Data designed to enhance efficiency and productivity of its clients’ drug and medical device pipelines.
The platform has been launched throughout the CRO to help support digital trials and patient interaction so that medical professionals can reach those who need it, a Dimension Data spokesperson said in an e-mail.
The platform was designed to aid in reducing complexity and cost for drug and device companies in bring new products to market.
Last year, Icon launched a new, paperless solution for managing the clinical investigator financial disclosure forms mandated by the FDA. Known as Firecrest Financial Disclosure software, it allows sponsors to electronically gather, distribute, track and manage completion of the forms required under the regulatory agency’s rules. The Irish company hopes the system will lower the risks of regulatory noncompliance and reduce administrative costs versus traditional distribution and tracking.